Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

758
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
758
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

943
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
943
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Vaccinations01:51

Vaccinations

54.7K
Overview
54.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.6K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis.

Vaccine·2020
Same author

Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to <i>Mycobacterium tuberculosis</i>.

Frontiers in immunology·2018
Same author

Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.

Tuberculosis (Edinburgh, Scotland)·2018
Same author

GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.

Clinical and vaccine immunology : CVI·2017
Same author

Pillars Article: The Kinetics of Emergence and Loss of Mediator T Lymphocytes Acquired in Response to Infection with <i>Mycobacterium Tuberculosis</i>. <i>J. Immunol</i>. 1987. 138: 293-298.

Journal of immunology (Baltimore, Md. : 1950)·2017
Same author

Mouse and Guinea Pig Models of Tuberculosis.

Microbiology spectrum·2016

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Tuberculosis vaccine types and timings.

Ian M Orme1

  • 1Colorado State University, Fort Collins, Colorado, USA ian.orme@colostate.edu.

Clinical and Vaccine Immunology : CVI
|December 26, 2014
PubMed
Summary
This summary is machine-generated.

New Mycobacterium tuberculosis vaccines offer diverse applications beyond traditional prophylactic use. These novel candidates aim to prevent infection, aid chemotherapy, and reduce disease reactivation, expanding tuberculosis control strategies.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.3K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.3K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Mycobacterium tuberculosis remains a significant global health threat.
  • Traditional vaccine design focused on early-life prophylactic Mycobacterium bovis Calmette-Guérin (BCG).
  • Emerging vaccine candidates present diverse application strategies.

Purpose of the Study:

  • To review novel vaccine candidates against Mycobacterium tuberculosis.
  • To explore varied applications beyond prophylaxis.
  • To discuss targeted immunity and limitations of new approaches.

Main Methods:

  • Review of current and developing vaccine strategies for tuberculosis.
  • Analysis of different vaccine administration scenarios.
  • Discussion of immunological targets and challenges.

Main Results:

  • Multiple vaccine types are under development for tuberculosis.
  • Applications include prophylactic, post-exposure, chemotherapy-facilitating, and relapse-prevention vaccines.
  • Specific immune responses and limitations are being investigated.

Conclusions:

  • Vaccine development for tuberculosis is diversifying.
  • New strategies aim for broader applications and improved outcomes.
  • Understanding targeted immunity and overcoming limitations are crucial for success.